Call 888-776-0942 from 8 a.m. to 10 p.m. Eastern Time

Expansion of micro metal processing capabilities in Silicon Valley and CT

Salt Lake City, October 25, 2021/PRNewswire/-Biomerics LLC, a leading mid-market contract manufacturer in the interventional medical device market, announced that it will double its micromachining capabilities and add additional metal capabilities. The Santa Clara, California plant has added four new Willemin-Macodel machining centers. In addition, there are plans to install another eight systems at the facility in Monroe, Connecticut, four by the end of the year and four by mid-2022. "Just three months after joining the Biomerics family, our service demand has seen unprecedented growth," said Jason McCash, senior vice president of micromachining. "We are installing the machine as soon as possible and are happy to be able to expand and bring our expertise to CT operations."

CT and MN facilities are also implementing expansion plans, including floor space, capital equipment, and manufacturing technology. Rich Rosselli, President of Biomerics NLE, said: “We have added a fifth Swiss machine with an integrated laser to the CT facility, as well as other manufacturing technologies besides micromachining.” “We installed the coil winding in the CT and installed it in the MN. Guide wire profile grinding and additional laser tube cutting capabilities are targeted at microcatheters, flexible needles and steerable endoscopic equipment." 

Travis Sessions, CEO of Biomerics, said: "I am very satisfied with the way the CT and CA teams seamlessly integrate and collaborate in this major expansion." "This increase in demand is exactly what we started building Biomerics two years ago. Part of what was expected. The medical device market needs contract manufacturers that can meet the highest quality standards and still respond flexibly enough to meet the market’s needs for speed and scale. Biomerics provides all of this in a vertically integrated organization."

Biomerics continues to execute its vision of creating end-to-end micrometal solutions for the intervention market, including organic and strategic acquisitions, by actively seeking vertical integration opportunities for hypotube, MIM, and advanced grinding operations.

Founded in 1993, Biomerics is a mid-market medical device contract manufacturer serving the interventional cardiovascular, gastrointestinal and advanced surgical markets. As a vertically integrated partner, Biomerics provides services to 20 of the top 30 medical equipment OEMs. Biomerics provides engineering development services, technology transfer manufacturing services and contract manufacturing services for finished medical devices through different locations in the United States and Costa Rica. Biomerics is a leader in the fields of biomaterials, injection molding, extrusion, micro metal processing, medical balloons, catheter assembly and finished packaging. Biomerics operates under the certified ISO 13485:2016 quality system and is registered with the FDA.

More news releases on similar topics

Cision Distribution 888-776-0942 8 a.m. to 9 p.m. Eastern Time